ConductScience.org, home

Paper41008951

Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer's Disease: A Metabolic Perspective.

Boccardi V and 2 others. Antioxidants (Basel), 2025. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer's Disease: A Metabolic Perspective. Papers, record 41008951. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008951

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer's Disease: A Metabolic Perspective.
PubMed
Journal
Antioxidants (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
9.16, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boccardi VVirginiahttps://orcid.org/0000-0003-2134-1122
2Mancinetti FFrancesca
3Mecocci PPatriziahttps://orcid.org/0000-0003-0729-5246

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References75

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122019011RAGE: a single receptor fits multiple ligands.Trends Biochem Sci2011https://conductscience.org/library/papers/22019011PubMed
240023293Mitochondrial dysfunction in Alzheimer's disease.Ageing Res Rev2025https://conductscience.org/library/papers/40023293PubMed
341027400Ultra-processed Food Consumption in Youth and Adults: United States, August 2021-August 2023.NCHS Data Brief2025https://conductscience.org/library/papers/41027400PubMed
438790679Protein Oxidation in Aging and Alzheimer's Disease Brain.Antioxidants (Basel)2024https://conductscience.org/library/papers/38790679PubMed
521945540Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.Neurobiol Dis2012https://conductscience.org/library/papers/21945540PubMed
632824102Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease.Int J Mol Sci2020https://conductscience.org/library/papers/32824102PubMed
739032613Pivotal role of AGE-RAGE axis in brain aging with current interventions.Ageing Res Rev2024https://conductscience.org/library/papers/39032613PubMed
837815901Microglia and Astrocytes in Alzheimer's Disease: Significance and Summary of Recent Advances.Aging Dis2024https://conductscience.org/library/papers/37815901PubMed
99798928Increased nuclear DNA oxidation in the brain in Alzheimer's disease.J Neurochem1998https://conductscience.org/library/papers/9798928PubMed
1023855502The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease.Int J Neurosci2014https://conductscience.org/library/papers/23855502PubMed
118610103Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8610103PubMed
1226175217Role of RAGE in Alzheimer's Disease.Cell Mol Neurobiol2016https://conductscience.org/library/papers/26175217PubMed
1315905958Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.Cell Mol Life Sci2005https://conductscience.org/library/papers/15905958PubMed
1439176029Dietary advanced glycation end-products and their associations with body weight on a Mediterranean diet and low-fat vegan diet: a randomized, cross-over trial.Front Nutr2024https://conductscience.org/library/papers/39176029PubMed
1539200352Insulin Resistance, a Risk Factor for Alzheimer's Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach.Biomedicines2024https://conductscience.org/library/papers/39200352PubMed
1636154605Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.Curr Neuropharmacol2023https://conductscience.org/library/papers/36154605PubMed
1739236855Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier.Ageing Res Rev2024https://conductscience.org/library/papers/39236855PubMed
1840511089A Review Article on Oxidative Stress Markers F2-Isoprostanes and Presenilin-1 in Alzheimer's Disease.J Pharm Bioallied Sci2025https://conductscience.org/library/papers/40511089PubMed
1924845678ROS function in redox signaling and oxidative stress.Curr Biol2014https://conductscience.org/library/papers/24845678PubMed
2037509717Current Understanding of Polyphenols to Enhance Bioavailability for Better Therapies.Biomedicines2023https://conductscience.org/library/papers/37509717PubMed

See all 75 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42943013Dietary and Circulating Advanced Glycation End Products in Relation to Inflammation and Cognitive Function in Healthy Young Adults.Nutrients2026https://conductscience.org/library/papers/42943013PubMed
42923488Protein glycosylation and glycation in Alzheimer's disease: mechanisms, crosstalk, and therapeutic perspectives.Front Neurosci2026https://conductscience.org/library/papers/42923488PubMed
42871839Advanced Glycation End Products: From Pathogenesis to Treatment.MedComm (2020)2026https://conductscience.org/library/papers/42871839PubMed
42709392From Glycation to Toxicity: α-Synuclein Oligomers, Oxidative Stress, and Multi-Targeted Protection by Trans-Ferulic Acid.Cell Biochem Biophys2026https://conductscience.org/library/papers/42709392PubMed
42703487Exposome influences: a multi-omics perspective on the combined toxic effects of pharmaceuticals and personal care products in Alzheimer's disease.Front Toxicol2026https://conductscience.org/library/papers/42703487PubMed
42553297Targeting mitochondria for the treatment of neurodegenerative diseases.Front Neurosci2026https://conductscience.org/library/papers/42553297PubMed
42524345Regulation by Ascorbic Acid and HOO• Radicals of Extracellular DNA Network Formation and Internalization Activity of Mononuclear Cells.Sovrem Tekhnologii Med2026https://conductscience.org/library/papers/42524345PubMed
42375880Advanced Glycation End Products and Genetic Polymorphism in the Pathogenesis of Microvascular Complications in Type 2 Diabetes Mellitus: A Narrative Review.Cureus2026https://conductscience.org/library/papers/42375880PubMed
42196318Physical Exercise Counteracts Impaired Cognition by Improving Mitochondrial Function.Int J Mol Sci2026https://conductscience.org/library/papers/42196318PubMed
42137842Oxidative stress as a converging mechanism of aging and neurodegeneration: From molecular pathways to therapeutic targets.Narra J2026https://conductscience.org/library/papers/42137842PubMed
42114333Protein glycoxidation in neuropsychiatric disorders-from basic research to clinical practice.Redox Biol2026https://conductscience.org/library/papers/42114333PubMed
42020356The iron-energy metabolism axis in Alzheimer's pathogenesis: from mechanisms to interventions.Cell Death Discov2026https://conductscience.org/library/papers/42020356PubMed
41944346Natural Chiral Scaffolds in Alzheimer's Disease: Therapeutic Potential, Mechanism, and Clinical Aspects.Biomed Res Int2026https://conductscience.org/library/papers/41944346PubMed
41829958Effect of a Nutraceutical Combination on Oxidative Stress Biomarkers in Healthy Subjects and Patients with Alzheimer's Disease.Nutrients2026https://conductscience.org/library/papers/41829958PubMed
41750311AGE-RAGE Axis Involvement in Allergies and Autoimmunity: Cellular Signaling, Barrier Dysfunction and Immune Polarization.Biomolecules2026https://conductscience.org/library/papers/41750311PubMed
41619187How Do Amyloid Pathology and Aberrant Neuronal Activity Disrupt Plasticity and Memory in Alzheimer's Disease?Neuroscientist2026https://conductscience.org/library/papers/41619187PubMed
41527682The complexity of dementia development and its comorbidities: The collaborative cross-mouse population for multivarious tasks approach.Animal Model Exp Med2026https://conductscience.org/library/papers/41527682PubMed
41517108Chemical Characterization of Phenol-Rich Olive Leaf Extract (Olea europaea L. cv. Ogliarola) and Its Neuro-Protective Effects on SH-SY5Y Cells from Oxidative Stress, Lipid Peroxidation, and Glycation.Foods2025https://conductscience.org/library/papers/41517108PubMed
41516384Propyl Gallate Attenuates Methylglyoxal-Induced Alzheimer-like Cognitive Deficits and Neuroinflammation in Mice.Int J Mol Sci2026https://conductscience.org/library/papers/41516384PubMed
41226584The Glymphatic-Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, Biomarker Imaging, and Precision Therapeutic Frontiers.Int J Mol Sci2025https://conductscience.org/library/papers/41226584PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGER177PubTator's text mininghttps://conductscience.org/library/genes/177NCBI Gene
RENBP5973PubTator's text mininghttps://conductscience.org/library/genes/5973NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41008951

GET https://conductscience.org/api/papers/v1/41008951/references?page=2